LAS VEGAS, Dec. 10, 2024 /PRNewswire/ — The veterinary vaccines market is experiencing robust growth driven by factors such as the rising prevalence of zoonotic diseases, increasing concerns about antimicrobial resistance in animals, and a growing demand for...
Cartesian Therapeutics reported longer-term results from a mid-stage study of its mRNA CAR-T therapy for myasthenia gravis, suggesting that the therapy is durable beyond the initial three-month study period. In 12 patients, the mean decrease at six months in a...
The success of mRNA vaccines has sparked significant interest and investment in using mRNA technology to treat a broad range of diseases, including cancer, infectious diseases, and rare conditions. Yet when “naked” RNA is injected, it degrades quickly. To address this...
GSK on Tuesday unveiled a lawsuit filed against Moderna in Delaware federal court, alleging that its patented inventions provide the “foundation” for Moderna’s mRNA vaccine portfolio. GSK said it’s looking to recover “a reasonable royalty” for Moderna’s tens of...
Credit: Unsplash/CC0 Public Domain The most frequently used mpox vaccine provides partial immunity to the disease but isn’t always able to prevent severe symptoms or disease transmission. A new vaccine candidate from Moderna, mRNA-1769, more effectively limits...
